Analyst Ratings for Moderna (MRNA) [Buys]
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $506.00 (Brookline Capital Markets)
- Lowest: $131.00 (JPMorgan)
- Average: $237.57
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$237.57 (+63.4%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 33%
Rating Score: 3.8 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/8/2021 | Wolfe Research » Updated 5/4/2022 |
Andrew Galler | New Coverage | Outperform (N/A) |
261.00 (N/A) |
236.99 (145.36) |
-38.66% | Details |
10/15/2021 | Piper Sandler » Updated 6/22/2022 |
Edward A. Tenthoff | Upgrade | Overweight (Neutral) |
214.00 (N/A) |
321.50 (145.36) |
-54.79% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |